在HER2+乳腺癌中,氧化还原调节,免疫激活和治疗反应之间的相互作用
Paulo Luz1, Sofia Ramos2, Maria José Oliveira3
1CBIOS, Universidade Lusófona's Research Center for Biosciences & Health Technologies, Lisbon, Portugal; Universidad de Alcalá de Henares. Departamento de Ciencias Biomédicas, Alcalá de Henares, Madrid, Spain; Medical Oncology Department, Unidade Local de Saúde do Baixo Alentejo - Hospital José Joaquim Fernandes, Beja, Portugal.
Redox biology
|April 2, 2025
概括
瘤透淋巴细胞 (TIL) 和活性氧物种 (ROS) 可能预测HER2+乳腺癌的治疗反应. 对这些生物标志物的进一步研究可以个性化新辅助疗法,以获得更好的患者结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 在HER2+乳腺癌 (BC) 中,新辅助疗法旨在获得病理完整反应 (pCR),与预后改善有关.
- 生物标志物对于在HER2+BC中个性化新辅助治疗至关重要.
- 瘤透淋巴细胞 (TILs) 在预测pCR和转移性疾病的结果方面表现有前途.
研究的目的:
- 审查治疗反应,免疫激活和HER2+BC中的反应性氧物种 (ROS) 之间的相互作用.
- 探索TILs和ROS作为新辅助疗法的预测生物标志物的潜力.
- 根据这些相互作用,提出新的研究和干预策略.
主要方法:
- 关于HER2+BC中的TILs,ROS和治疗反应的文献综述.
- 对与氧化还原相关的基因表达和免疫细胞种群的生物信息分析.
- 基因表达,免疫透和患者存活率之间的相关性分析.
主要成果:
- 与氧化还原相关基因的改变表达与瘤微环境中的免疫细胞患病率相关.
- 这些基因表达模式与HER2+BC患者的存活率有关.
- 在HER2+BC中TILs和ROS之间的相互作用需要进一步研究.
结论:
- TIL和ROS代表了在HER2+BC中定制新辅助疗法的潜在生物标志物.
- 需要进一步的研究来验证这些生物标志物,并制定有针对性的干预措施.
- 个性化治疗策略可以通过了解瘤免疫微环境和氧化还原状态来增强.
更多相关视频
相关概念视频
Inflammatory Response
1.7K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.7K
Tumor Immunotherapy
432
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
432
Positive Regulator Molecules
105.6K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
105.6K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Target Cell Response to Hormones
2.8K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
2.8K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K


